Category Archives: Healthcare

The SVP & CAO of Ultragenyx Pharmaceutical (NASDAQ: RARE) is Selling Shares

Yesterday, the SVP & CAO of Ultragenyx Pharmaceutical (RARE – Research Report), Theodore Alan Huizenga, sold shares of RARE for $11.36K. In addition to Theodore Alan Huizenga, 7 other RARE executives reported Sell trades in the last month. See today’s

The EVP of Translational Sciences and Chief Quality Of of Ultragenyx Pharmaceutical (NASDAQ: RARE) is Selling Shares

Yesterday, the EVP of Translational Sciences and Chief Quality Of of Ultragenyx Pharmaceutical (RARE – Research Report), John Richard Pinion, sold shares of RARE for $29.05K. In addition to John Richard Pinion, 7 other RARE executives reported Sell trades in

BiomX (PHGE) Receives a Buy from H.C. Wainwright

In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on BiomX (PHGE – Research Report), with a price target of $10.00. The company’s shares closed last Monday at $2.25. According to TipRanks.com, Pantginis is a

Analysts Offer Insights on Healthcare Companies: Biogen (NASDAQ: BIIB), Pacira Pharmaceuticals (NASDAQ: PCRX) and Intra-Cellular Therapies (NASDAQ: ITCI)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Biogen (BIIB – Research Report), Pacira Pharmaceuticals (PCRX – Research Report) and Intra-Cellular Therapies (ITCI – Research Report) with bullish sentiments. Biogen

Raymond James Thinks Ocular Therapeutix’s Stock is Going to Recover

In a report released today, Dane Leone from Raymond James maintained a Buy rating on Ocular Therapeutix (OCUL – Research Report), with a price target of $29.00. The company’s shares closed last Friday at $11.19, close to its 52-week low

Vicarious Surgical (RBOT) Initiated with a Buy at BTIG

BTIG analyst Ryan Zimmerman initiated coverage with a Buy rating on Vicarious Surgical (RBOT – Research Report) today and set a price target of $15.00. The company’s shares closed last Friday at $10.57. According to TipRanks.com, Zimmerman is a 5-star